Will Roberts

Will Roberts joined G1 as Vice President, Investor Relations and Corporate Communications in 2021. Mr. Roberts has nearly 30 years of biotechnology/pharmaceutical experience in corporate and product communications, investor and public relations, patient advocacy, and preclinical research.

Mr. Roberts previously served as Vice President, Investor Relations and Corporate Communications at Zynerba Pharmaceuticals. Prior, he served as Vice President, Corporate Communications for Adaptimmune Therapeutics, where he supported the company’s IPO and developed its communications strategies. He spent 10 years with ViroPharma Inc., a biotechnology company recognized for excellence in investor relations and communications, culminating in his tenure as Vice President, Corporate Communications. He was responsible for leading global investor and corporate communications, patient advocacy, disease awareness programming, and global communications support for the company’s marketed products. He began his career at MedImmune, spending 12 years with the company and transitioning from his initial role as a molecular microbiology research scientist into investor relations in 1997.

Mr. Roberts received a B.A. in biology from the University of Virginia, and an M.B.A. from the Keller Graduate School of Management.